Davina Little, APRN
Nurse Practitioner · Augusta, KSNPI 1902412117
Payments from drug & device makers
Across 289 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$808
- Bayer$571
- Novo Nordisk$523
- Lilly USA, LLC$408
- Astellas Pharma US Inc$290
- plus $1K from 27 others
What the payments were for
- Food & beverage$5,115100%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $1,042 |
| AbbVie | 57 | $808 |
| Bayer | 36 | $571 |
| Novo Nordisk | 35 | $523 |
| Lilly USA, LLC | 28 | $408 |
| Astellas Pharma US Inc | 18 | $290 |
| Idorsia Pharmaceuticals US Inc | 10 | $244 |
| Vanda Pharmaceuticals Inc. | 4 | $159 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $157 |
| Amgen | 6 | $107 |
| Currax Pharmaceuticals LLC | 6 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $65 |
| Johnson & Johnson | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Merck | 3 | $52 |
| Pfizer | 3 | $47 |
| Dexcom, Inc. | 2 | $40 |
| Inspire Medical Systems, Inc. | 2 | $32 |
| GSK | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $29 |
| Exact Sciences | 2 | $28 |
| Seqirus USA Inc | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Novartis | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Biogen | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,140 in reported general payments places this provider in the 95th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 19 | $21,606 |
| XareltoRivaroxaban | 15 | $13,002 |
| FarxigaDapagliflozin Propanediol | 23 | $12,637 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,373 |
| OzempicSemaglutide | 11 | $9,864 |
| EliquisApixaban | 16 | $8,695 |
| KerendiaFinerenone | 13 | $8,210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 62 | $1,674 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,010 |
| Gabapentin | 42 | $583 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $462 |
| Pregabalin | 17 | $458 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $393 |
| Omeprazole | 28 | $374 |
| Methylprednisolone | 41 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $1,042 | $25,00943 claims |
| Lilly USA, LLCMounjaro | $408 | $21,60619 claims |
| Johnson & JohnsonXarelto | $65 | $13,00215 claims |
| Novo NordiskOzempic | $523 | $9,86411 claims |
| PfizerEliquis | $47 | $8,69516 claims |
| BayerKerendia | $571 | $8,21013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 nurse practitioner providers in Kansas.
Other nurse practitioner in Augusta
- Gary GrafTopeka$726K
- Sarah FitzmauriceKansas City$247K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
- Lori RanalloWestwood$48K
- Kristyn MilburnPleasanton$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.